| Issue Date | Title | Author(s) |
| 1-Oct-2021 | Acylation of the incretin peptide exendin-4 directly impacts GLP-1 receptor signalling and trafficking | Lucey, M; Ashik, T; Marzook, A; Wang, Y; Goulding, J, et al |
| Feb-2019 | The effects of high protein diets and L-Phenylalanine on energy and glucose homeostasis | Murphy, Kevin; Frost, Gary; Salem, Victoria; Norton, Mariana; , et al |
| Aug-2021 | Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1 | Marzook, A; Chen, S; Pickford, P; Lucey, M; Wang, Y, et al |
| 2021 | Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signalling at glucagon family receptors | Jones, B; McGlone, ER; Fang, Z; Pickford, P; Corrêa, IR, et al |
| 9-Nov-2020 | Ligand-specific factors influencing GLP-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells | Jones, B; Fang, Z; Chen, S; Manchanda, Y; Bitsi, S, et al |
| 1-Sep-2021 | Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist | Pickford, P; Lucey, M; Rujan, R-M; McGlone, ER; Bitsi, S, et al |
| May-2021 | The interplay of glucagon-like peptide-1 receptor trafficking and signalling in pancreatic beta cells | Marzook, A; Tomas, A; Jones, B; , et al |
| Feb-2022 | The metabolomic effects of tripeptide gut hormone infusion compared to Roux-en-Y gastric bypass and caloric restriction | Sands, C; Alexiadou, K; Minnion, J; Tharakan, G; Behary, P, et al |
| 1-Feb-2022 | The therapeutic potential of GLP-1 receptor biased agonism | Jones, B; , et al |